<DOC>
	<DOCNO>NCT01004718</DOCNO>
	<brief_summary>RATIONALE : Imaging procedure , positron emission tomography compute tomography , may help detect difference Hodgkin lymphoma diffuse large B-cell lymphoma cancer cell . PURPOSE : This clinical trial study positron emission tomogaphy compute tomography determine difference Hodgkin lymphoma diffuse large B-cell lymphoma .</brief_summary>
	<brief_title>Detection Quant Differences Hodgkin Lymphoma Diffuse Large B-cell Lymphoma Using Positron Emission Tomography/Computed Tomography ( PET/CT )</brief_title>
	<detailed_description>OBJECTIVES : I. Assess feasibility detection quantification difference temporal spatial distribution FDG uptake lesion HL DLBCL . OUTLINE : Patients undergo fludeoxyglucose F18 ( FDG ) positron emission tomography/computed tomography scan 60 180 minute FDG administration . After completion study , patient follow 24 hour .</detailed_description>
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Hodgkin Disease</mesh_term>
	<mesh_term>Lymphoma , B-Cell</mesh_term>
	<mesh_term>Lymphoma , Large B-Cell , Diffuse</mesh_term>
	<mesh_term>Fluorodeoxyglucose F18</mesh_term>
	<criteria>Subjects pathologicallyproven diagnosis classic HL DLBCL measurable disease image technique physical examination . Pregnant nursing , Uncontrolled diabetes mellitus , Active infection , Inability give inform consent comply study procedure , Subjects may exclude discretion principal investigator study team member .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>